Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Step 2: Online Consultation Connect with a licensed provider through a telehealth visit
One episode of severe hypoglycemia (requiring the assistance of another person) was reported in one WEGOVY treated patient versus no placebo-treated patients [see Clinical Studies (14.2)]
Treatment significantly reduced levels of pro-inflammatory cytokines including interleukin-1 (IL-1) and tumor necrosis factor- (TNF-) while increasing anti-inflammatory interleukin-10 (IL-10) expression
Laws and regulations change frequently, and the information may not reflect the most current developments
Wegovy (semaglutide) injection 2.4 mg is an injectable prescription medicine used for adults with obesity (BMI 30) or overweight (excess weight) (BMI 27) who also have weight-related medical problems to help them lose weight and keep the weight off
US$ 27.08
US$ 20.73
US$ 28.33
US$ 26.63
US$ 29.82
US$ 26.71
US$ 24.88
